Hello friends.
Just diagnosed. Intermediate risk stage. I am concerned my PSA (0.7/3yrs) is not indicating true risk. Sister with breast, father melo. PNI in base core sample. 23andME says negative on BCRA1/2 (mpMRI coming. 2nd biopsy opinion coming).
It looks to me like i am trending more towards unfavourable due to some higher risk factors.
So not sure it matters now to get additional genomic tests in terms of treatment decision.
I also find that Polaris, Onco, Decipher show significant discordance between tests, with NCCN risk criteria. medpagetoday.com/meetingcov.... Not sure how to think about this.
Question now: is genomic evaluation potentially helpful given my particulars?
Should i get more than one or all three? Insurance coverage is don't care.
How does 23andME compare given result i have?
Thanks for any help, 45r